Sio Gene Therapies downgraded by SVB Leerink with a new price target

2/1/22 6:26:53 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

SVB Leerink downgraded Sio Gene Therapies from Outperform to Market Perform and set a new price target of $1.00 from $6.00 previously

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$SIOX

Date	Price Target	Rating	Analyst
2/1/2022	$10.00 → $7.00	Buy	HC Wainwright & Co.
2/1/2022	$6.00 → $1.00	Outperform → Market Perform	SVB Leerink
10/21/2021	$8.00 → $10.00	Buy	HC Wainwright & Co.
8/12/2021	$7.00 → $6.00	Outperform	SVB Leerink
7/12/2021	$12.50	Buy	Chardan Capital Markets